Huidagene Therapeutics

Shanghai, China · Founded 2018 · Privately Held (backing)

Developer of gene therapy drugs designed for the treatments of rare human genetic diseases. Huidagene Therapeutics is based in Shanghai, China and was founded in 2018. It has raised $80.4 million.

Last price · $/share

—

Implied valuation

—

Total raised

$80.4M

Last round

—

How much has Huidagene Therapeutics raised?

$80.4Macross 0 recorded rounds

Free account

More of Huidagene Therapeutics with a free account

·Watch Huidagene Therapeutics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Huidagene Therapeutics investors

7 investors are on record for Huidagene Therapeutics, including GL Ventures, Beijing Ruiyin Weiye Technology Development, HM Capital and HM Venture Partners.

For fundraisers

Raising for a company like Huidagene Therapeutics?

7 investors have backed Huidagene Therapeutics.

See all 7 investors →

Frequently asked about Huidagene Therapeutics

How much has Huidagene Therapeutics raised?: Huidagene Therapeutics has raised $80.4M in total across 0 recorded funding rounds.